US Stock MarketDetailed Quotes

TTNPW TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Oct 9 16:00 ET
0Market Cap0.00P/E (TTM)

TITAN PHARMACEUTICAL INC C/WTS 18/10/2024(TO PUR COM) CL B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
-98.33%1K
0
0
-66.67%1K
0
-75.90%60K
1,175.00%51K
-90.00%4K
Operating revenue
--0
--0
-98.33%1K
--0
--0
-66.67%1K
--0
-75.90%60K
1,175.00%51K
-90.00%4K
Cost of revenue
Gross profit
Operating expense
30.52%2.07M
-37.36%1.06M
-29.31%7.28M
-27.46%1.93M
-22.14%2.06M
-35.01%1.59M
-33.24%1.7M
9.47%10.3M
6.78%2.66M
35.88%2.65M
Selling and administrative expenses
68.76%2.07M
-13.86%1.06M
-8.05%5.55M
12.02%1.44M
-9.14%1.64M
-24.04%1.23M
-6.66%1.23M
20.95%6.03M
-21.78%1.29M
84.47%1.81M
-General and administrative expense
68.76%2.07M
-13.86%1.06M
-8.05%5.55M
12.02%1.44M
-9.14%1.64M
-24.04%1.23M
-6.66%1.23M
20.95%6.03M
-21.78%1.29M
84.47%1.81M
Research and development costs
--0
--0
-59.79%1.91M
-66.25%487K
-54.51%424K
-54.62%442K
-60.18%561K
-16.41%4.76M
47.85%1.44M
-21.88%932K
Other operating expenses
----
----
63.18%-183K
--0
95.60%-4K
44.22%-82K
48.15%-98K
61.08%-497K
46.56%-70K
59.38%-91K
Operating profit
-30.60%-2.07M
37.36%-1.06M
28.90%-7.28M
26.04%-1.93M
22.02%-2.06M
34.97%-1.59M
33.16%-1.7M
-9.42%-10.24M
-4.90%-2.61M
-38.52%-2.64M
Net non-operating interest income expense
0
-95.45%1K
-90.57%5K
-148.15%-13K
-152.38%-11K
40.00%7K
22K
5,200.00%53K
800.00%27K
21K
Non-operating interest income
--0
-95.45%1K
-90.57%5K
----
----
40.00%7K
--22K
5,200.00%53K
----
----
Total other finance cost
----
----
----
----
152.38%11K
----
----
----
----
---21K
Other net income (expense)
-280.00%-19K
2K
7,195.83%1.7M
-244.44%-26K
10,937.50%1.73M
80.00%-5K
-104.16%-24K
133.33%18K
-128.57%-16K
Special income (charges)
----
----
--1.76M
--23K
--1.73M
----
----
--0
--0
--0
-Gain on sale of property,plant,equipment
----
----
--1.76M
--23K
--1.73M
----
----
--0
--0
--0
Other non- operating income (expenses)
-280.00%-19K
--2K
-116.67%-52K
-372.22%-49K
112.50%2K
80.00%-5K
----
71.43%-24K
133.33%18K
-128.57%-16K
Income before tax
-31.97%-2.09M
36.72%-1.06M
45.43%-5.57M
23.23%-1.97M
87.19%-338K
35.58%-1.59M
34.06%-1.68M
-16.29%-10.21M
-1.02%-2.57M
-37.75%-2.64M
Income tax
Net income
-31.97%-2.09M
36.72%-1.06M
45.43%-5.57M
23.23%-1.97M
87.19%-338K
35.58%-1.59M
34.06%-1.68M
-16.29%-10.21M
-1.02%-2.57M
-37.75%-2.64M
Net income continuous Operations
-31.97%-2.09M
36.72%-1.06M
45.43%-5.57M
23.23%-1.97M
87.19%-338K
35.58%-1.59M
34.06%-1.68M
-16.29%-10.21M
-1.02%-2.57M
-37.75%-2.64M
Minority interest income
Net income attributable to the parent company
-31.97%-2.09M
36.72%-1.06M
45.43%-5.57M
23.23%-1.97M
87.19%-338K
35.58%-1.59M
34.06%-1.68M
-16.29%-10.21M
-1.02%-2.57M
-37.75%-2.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.97%-2.09M
36.72%-1.06M
45.43%-5.57M
23.23%-1.97M
87.19%-338K
35.58%-1.59M
34.06%-1.68M
-16.29%-10.21M
-1.02%-2.57M
-37.75%-2.64M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00-98.33%1K00-66.67%1K0-75.90%60K1,175.00%51K-90.00%4K
Operating revenue --0--0-98.33%1K--0--0-66.67%1K--0-75.90%60K1,175.00%51K-90.00%4K
Cost of revenue
Gross profit
Operating expense 30.52%2.07M-37.36%1.06M-29.31%7.28M-27.46%1.93M-22.14%2.06M-35.01%1.59M-33.24%1.7M9.47%10.3M6.78%2.66M35.88%2.65M
Selling and administrative expenses 68.76%2.07M-13.86%1.06M-8.05%5.55M12.02%1.44M-9.14%1.64M-24.04%1.23M-6.66%1.23M20.95%6.03M-21.78%1.29M84.47%1.81M
-General and administrative expense 68.76%2.07M-13.86%1.06M-8.05%5.55M12.02%1.44M-9.14%1.64M-24.04%1.23M-6.66%1.23M20.95%6.03M-21.78%1.29M84.47%1.81M
Research and development costs --0--0-59.79%1.91M-66.25%487K-54.51%424K-54.62%442K-60.18%561K-16.41%4.76M47.85%1.44M-21.88%932K
Other operating expenses --------63.18%-183K--095.60%-4K44.22%-82K48.15%-98K61.08%-497K46.56%-70K59.38%-91K
Operating profit -30.60%-2.07M37.36%-1.06M28.90%-7.28M26.04%-1.93M22.02%-2.06M34.97%-1.59M33.16%-1.7M-9.42%-10.24M-4.90%-2.61M-38.52%-2.64M
Net non-operating interest income expense 0-95.45%1K-90.57%5K-148.15%-13K-152.38%-11K40.00%7K22K5,200.00%53K800.00%27K21K
Non-operating interest income --0-95.45%1K-90.57%5K--------40.00%7K--22K5,200.00%53K--------
Total other finance cost ----------------152.38%11K-------------------21K
Other net income (expense) -280.00%-19K2K7,195.83%1.7M-244.44%-26K10,937.50%1.73M80.00%-5K-104.16%-24K133.33%18K-128.57%-16K
Special income (charges) ----------1.76M--23K--1.73M----------0--0--0
-Gain on sale of property,plant,equipment ----------1.76M--23K--1.73M----------0--0--0
Other non- operating income (expenses) -280.00%-19K--2K-116.67%-52K-372.22%-49K112.50%2K80.00%-5K----71.43%-24K133.33%18K-128.57%-16K
Income before tax -31.97%-2.09M36.72%-1.06M45.43%-5.57M23.23%-1.97M87.19%-338K35.58%-1.59M34.06%-1.68M-16.29%-10.21M-1.02%-2.57M-37.75%-2.64M
Income tax
Net income -31.97%-2.09M36.72%-1.06M45.43%-5.57M23.23%-1.97M87.19%-338K35.58%-1.59M34.06%-1.68M-16.29%-10.21M-1.02%-2.57M-37.75%-2.64M
Net income continuous Operations -31.97%-2.09M36.72%-1.06M45.43%-5.57M23.23%-1.97M87.19%-338K35.58%-1.59M34.06%-1.68M-16.29%-10.21M-1.02%-2.57M-37.75%-2.64M
Minority interest income
Net income attributable to the parent company -31.97%-2.09M36.72%-1.06M45.43%-5.57M23.23%-1.97M87.19%-338K35.58%-1.59M34.06%-1.68M-16.29%-10.21M-1.02%-2.57M-37.75%-2.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.97%-2.09M36.72%-1.06M45.43%-5.57M23.23%-1.97M87.19%-338K35.58%-1.59M34.06%-1.68M-16.29%-10.21M-1.02%-2.57M-37.75%-2.64M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data